β-L-Xylopyranoside, Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-1-thio-, 2,3,4-triacetate,(5S)- manufacturers
|
| | β-L-Xylopyranoside, Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-1-thio-, 2,3,4-triacetate,(5S)- Basic information |
| Product Name: | β-L-Xylopyranoside, Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-1-thio-, 2,3,4-triacetate,(5S)- | | Synonyms: | acetic acid (2R,3S,4R,5S,6S)-4,5-diacetoxy-6-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-2-methylsulfanyl-tetrahydro-pyran-3 -yl ester;CPD0854-A4;SOTA-010;(2S,3S,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylthio)tetrahydropyran-3,4,5-triyl Triacetate;Methyl (5S)-5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-beta-L-xylopyranoside 2,3,4-triacetate;β-L-Xylopyranoside, Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-1-thio-, 2,3,4-triacetate,(5S)-;Sotagliflozin Impurity 2;Methyl(5S)-5-C-[4-chloro-3-[(4- ethoxyphenyl)methyl]pheny1]-1-thio-beta-L- xylopyranoside 2,3,4-triacetate | | CAS: | 1018899-03-0 | | MF: | C27H31ClO8S | | MW: | 551.05 | | EINECS: | 814-200-8 | | Product Categories: | | | Mol File: | 1018899-03-0.mol | ![β-L-Xylopyranoside, Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-1-thio-, 2,3,4-triacetate,(5S)- Structure](CAS/20150408/GIF/1018899-03-0.gif) |
| | β-L-Xylopyranoside, Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-1-thio-, 2,3,4-triacetate,(5S)- Chemical Properties |
| Boiling point | 617.6±55.0 °C(Predicted) | | density | 1.30±0.1 g/cm3(Predicted) | | InChIKey | ABNIXBQXMYTWSJ-FFVSIFNVNA-N | | SMILES | [C@@H]1(C2=CC=C(Cl)C(CC3=CC=C(OCC)C=C3)=C2)O[C@H](SC)[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H]1OC(=O)C |&1:0,19,22,27,32,r| | | LogP | 3.201 |
| | β-L-Xylopyranoside, Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-1-thio-, 2,3,4-triacetate,(5S)- Usage And Synthesis |
| | β-L-Xylopyranoside, Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-1-thio-, 2,3,4-triacetate,(5S)- Preparation Products And Raw materials |
|